PDF herunterladen
CC BY-NC-ND 4.0 · J Neuroanaesth Crit Care 2015; 02(01): 038-043
DOI: 10.4103/2348-0548.148387
Original Article
Thieme Medical and Scientific Publishers Private Ltd.

Do transfusion requirements increase after the diagnosis of vasospasm in patients with aneurysmal subarachnoid haemorrhage?

Lashmikumar Venkatraghavan
1   Departments of Anesthesia and Critical Care, University of Toronto, Toronto Western Hospital, University Health Network, Ontario, Canada
,
Sarah Tymianski
1   Departments of Anesthesia and Critical Care, University of Toronto, Toronto Western Hospital, University Health Network, Ontario, Canada
,
Jeffrey Singh
1   Departments of Anesthesia and Critical Care, University of Toronto, Toronto Western Hospital, University Health Network, Ontario, Canada
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
05. Mai 2018 (online)

   Lizenzen und Reprints

Abstract

Background: Many patients experience impaired cerebral oxygen delivery secondary to vasospasm and delayed cerebral ischemia following aneurysmal subarachnoid haemorrhage (SAH). Anaemia is common after SAH affecting up to 50% patients, which may decrease cerebral oxygen delivery and is associated with worse clinical outcomes. Transfusion of allogeneic red cells increases the oxygen content of the blood but it not consistently associated with improved physiologic markers of clinical outcomes. The threshold for transfusion is not clear in patients with SAH. A recent survey found that most physicians would alter their transfusion threshold in SAH patients who develop delayed ischemia. The objective of our study is to identify the predictors of transfusion and to determine if the diagnosis of delayed ischemia increases the transfusion rates in patients with aneurysmal subarachnoid haemorrhage. Materials and Methods: We retrospectively reviewed the charts of 100 consecutive patients with SAH who were admitted to ICU for mechanical ventilation, and collected demographic and clinical data. Data were analyzed for the association between clinical factors and transfusion the differences in transfusion between the patients with and without vasospasm. Statistical methods included the t-test, univariate analysis and multivariate analysis. Results: Data from 96 patients were included in the analysis. Incidence of anaemia haemoglobin (Hb) < 100 gm/l and vasospasm were 67% (64/96) and 39% (38/96) respectively. Of 64 patients with anaemia, 27 patients received transfusion, while 38 patients did not receive a transfusion. The transfusion rates were similar between those who had vasospasm and who did not. However, out of the 14 patients with vasospasm who received a transfusion, 11 patients had been transfused after experiencing vasospasm, while only 3 were transfused before. On multivariate analysis only female sex, starting Hb levels and lowest Hb levels were found to be predictors of transfusion. Presence or absence of vasospasm was not found to be a predictor. Conclusions: From our retrospective review, we conclude that the incidence of anaemia is higher in patients with vasospasm. Sex and starting and lowest Hb levels were the only predictors of transfusion likelihood in aneurysmal subarachnoid haemorrhage while presence of vasospasm was not.

Keywords

Anaemia - blood transfusion - subarachnoid haemorrrhage - vasospasm
 

  • REFERENCES

  • 1 Le Roux PD. Participants in the International Multi-disciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Anaemia and transfusion after subarachnoid hemorrhage. Neurocrit Care 2011; 15: 342-53
    CrossrefPubMedGoogle Scholar
  • 2 Kramer AH, Zygun DA, Bleck TP, Dumont AS, Kassell NF, Nathan B. Relationship between hemoglobin concentrations and outcomes across subgroups of patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care 2009; 10: 157-65
    CrossrefPubMedGoogle Scholar
  • 3 Longstreth Jr WT, Nelson LM, Koepsell TD, van Belle G. Clinical course of spontaneous subarachnoid hemorrhage: A population-based study in King County, Washington. Neurology 1993; 43: 712-8
    CrossrefPubMedGoogle Scholar
  • 4 Kramer AH, Gurka MJ, Nathan B, Dumont AS, Kassell NF, Bleck TP. Complications associated with anemia and blood transfusion in patients with aneurysmal subarachnoid hemorrhage. Crit Care Med 2008; 36: 2070-5
    CrossrefPubMedGoogle Scholar
  • 5 Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 2004; 101: 1-7
    CrossrefPubMedGoogle Scholar
  • 6 Dhar R, Zazulia AR, Videen TO, Zipfel GJ, Derdeyn CP, Diringer MN. Red blood cell transfusion increases cerebral oxygen delivery in anemic patients with subarachnoid hemorrhage. Stroke 2009; 40: 3039-44
    CrossrefPubMedGoogle Scholar
  • 7 Smith MJ, Stiefel MF, Magge S, Frangos S, Bloom S, Gracias V. et al. Packed red blood cell transfusion increases local cerebral oxygenation. Crit Care Med 2005; 33: 1104-8
    CrossrefPubMedGoogle Scholar
  • 8 Kurtz P, Helbok R, Claassen J, Schmidt J, Fernadez L, Stuart R. et al. Effect of packed red blood cell transfusion on cerebral oxygenation and metabolism after subarachnoid hemorrhage. Crit Care 2010; 14: P341
    CrossrefPubMedGoogle Scholar
  • 9 Gaehtgens P, Marx P. Hemorheological aspects of the pathophysiology of cerebral ischemia. J Cereb Blood Flow Metab 1987; 7: 259-65
    CrossrefPubMedGoogle Scholar
  • 10 Wood JH, Kee Jr. DB. Hemorheology of the cerebral circulation in stroke. Stroke 1985; 16: 765-72
    CrossrefPubMedGoogle Scholar
  • 11 Walsh TS, McArdle F, McLellan SA, Maciver C, Maginnis M, Prescott RJ. et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients?. Crit Care Med 2004; 32: 364-71
    CrossrefPubMedGoogle Scholar
  • 12 Doctor A, Platt R, Sheram ML, Eischeid A, McMohan T, Maxey T. et al. Hemoglobin conformation couples erythrocyte S-nitrosothiol content to O2 gradients. Proc Natl Acad Sci U S A 2005; 102: 5709-14
    CrossrefPubMedGoogle Scholar
  • 13 Moore EE. Blood substitutes: The future is now. J Am Coll Surg 2003; 196: 1-17
    CrossrefPubMedGoogle Scholar
  • 14 Borgstrom L, Johannsson H, Siesjo BK. The influence of acute hormovolemic anemia on cerebral blood flow and oxygen consumption of anesthetized rats. Acta Physiol Scand 1975; 93: 505-14
    CrossrefPubMedGoogle Scholar
  • 15 McLaren AT, Marsden PA, Mazer CD, Baker AJ, Stewart DJ, Tsui AK. et al. Increased expression of HIF-1alpha, nNOS, and VEGF in the cerebral cortex of anemic rats. Am J Physiol Regul Integr Comp Physiol 2007; 292: R403-14
    CrossrefPubMedGoogle Scholar
  • 16 Dexter F, Hindman BJ. Effect of haemoglobin concentration on brain oxygenation in focal stroke: A mathematical modeling study. Br J Anaesth 1997; 79: 346-51
    CrossrefPubMedGoogle Scholar
  • 17 Naidech AM, Jovanovic B, Wartenberg KE, Parra A, Ostapkovich N, Connolly ES. et al. Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage. Crit Care Med 2007; 35: 2383-9
    CrossrefPubMedGoogle Scholar
  • 18 Naidech AM, Drescher J, Ault ML, Shaibani A, Batjer HH, Alberts MJ. Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage. Neurosurgery 2006; 59: 775-9
    CrossrefPubMedGoogle Scholar
  • 19 Kramer AH, Diringer MN, Suarez JI, Naidech AM, Macdonald LR, Le Roux PD. Red blood cell transfusion in patients with subarachnoid hemorrhage: A multidisciplinary North American survey. Crit Care 2011; 15: R30
    CrossrefPubMedGoogle Scholar
  • 20 Bederson JB, Connolly Jr ES, Batjer HH, Dacey RG, Dion JE, Diringer MN. et al. American Heart Association. Guidelines for the management of aneurysmal subarachnoid hemorrhage: A statement for healthcare professionals from a special writing group of the Stroke Council. American Heart Association. Stroke 2009; 40: 994-1025
    CrossrefPubMedGoogle Scholar
  • 21 Diringer MN, Bleck TP, Claude Hemphill 3rd J, Menon D, Shutter L, Vespa P. et al. Neurocritical Care Society. Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference. Neurocrit Care 2011; 15: 211-40
    CrossrefPubMedGoogle Scholar
  • 22 Pendem S, Rana S, Manno EM, Gajic O. A review of red cell transfusion in the neurological intensive care unit. Neurocrit Care 2006; 4: 63-7
    CrossrefPubMedGoogle Scholar
  • 23 Haley Jr EC, Kassell NF, Torner JC. A randomized trial of nicardipine in subarachnoid hemorrhage: Angiographic and transcranial Doppler ultrasound results. A report of the Cooperative Aneurysm Study. J Neurosurg 1993; 78: 548-53
    CrossrefPubMedGoogle Scholar
  • 24 Sampson TR, Dhar R, Diringer MN. Factors associated with the development of anemia after subarachnoid hemorrhage. Neurocrit Care 2009; 12: 4-9
    PubMedGoogle Scholar
  • 25 Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N. et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med 2006; 34: 617-23
    CrossrefPubMedGoogle Scholar
  • 26 Awad IA, Carter LP, Spetzler RF, Medina M, Williams Jr. FC. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension. Stroke 1987; 18: 365-72
    CrossrefPubMedGoogle Scholar
  • 27 Kurtz P, Schmidt JM, Claassen J, Carrera E, Fernandez L, Helbok R. et al. Anemia is associated with metabolic distress and brain tissue hypoxia after subarachnoid hemorrhage. Neurocrit Care 2010; 13: 10-6
    CrossrefPubMedGoogle Scholar
  • 28 Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G. et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17
    CrossrefPubMedGoogle Scholar
  • 29 Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J. et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 2001; 29: 227-34
    CrossrefPubMedGoogle Scholar
  • 30 Levine J, Kofke A, Cen L, Chen Z, Faerber J, Elliott JP. et al. Red blood cell transfusion is associated with infection and extracerebral complications after subarachnoid hemorrhage. Neurosurgery 2010; 66: 312-8
    CrossrefPubMedGoogle Scholar
  • 31 Broessner G, Lackner P, Hoefer C, Beer R, Helbok R, Grabmer C. et al. Influence of red blood cell transfusion on mortality and long-term functional outcome in 292 patients with spontaneous subarachnoid hemorrhage. Crit Care Med 2009; 37: 1886-92
    CrossrefPubMedGoogle Scholar
  • 32 Zygun DA, Nortje J, Hutchinson PJ, Timofeev I, Menon DK, Gupta AK. The effect of red blood cell transfusion on cerebral oxygenation and metabolism after severe traumatic brain injury. Crit Care Med 2009; 37: 1074-8
    CrossrefPubMedGoogle Scholar
  • 33 Roback JD, Neuman RB, Quyyumi A, Sutliff R. Insufficient nitric oxide bioavailability: A hypothesis to explain adverse effects of red blood cell transfusion. Transfusion 2011; 51: 859-66
    CrossrefPubMedGoogle Scholar
  • 34 Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurol Res 2006; 28: 730-7
    CrossrefPubMedGoogle Scholar
  • 35 Rosenberg NF, Koht A, Naidech A. Anemia and transfusion after aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol 2013; 25: 66-74
    CrossrefPubMedGoogle Scholar